Alkermes

In News

Alkermes will break down Q1 results in a May 5 webcast at 8 a.m. ET - Stock Titan

Stock Titan - Apr 21, 2026

Alkermes to Present Sustained Efficacy Data for Alixorexton in Narcolepsy Type 1 - Sleep Review

Sleep Review - Apr 20, 2026

Alkermes Earns RS Rating Upgrade - Investor's Business Daily

Investor's Business Daily - Apr 17, 2026

Avadel Stock Rises After Acquisition Offer By Alkermes - MSN

MSN - Apr 19, 2026

Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at the American Academy of Neurology (AAN) 2026 Annual Meeting - BioSpace

BioSpace - Apr 17, 2026

Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc - PR Newswire

PR Newswire - Nov 19, 2025

Alkermes to present narcolepsy drug data at neurology meeting - Investing.com

Investing.com - Apr 16, 2026

Alkermes’ Alixorexton Shows Positive Phase II Results in Narcolepsy Type 2 - Applied Clinical Trials Online

Applied Clinical Trials Online - Nov 12, 2025

Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market - Yahoo Finance

Yahoo Finance - Feb 12, 2026

Alkermes Reveals CEO Succession Plan Following Richard Pops’ Retirement Announcement - Pharmaceutical Executive

Pharmaceutical Executive - Feb 26, 2026

Alkermes’ Richard Pops to step down after three-decade run as CEO - BioPharma Dive

BioPharma Dive - Feb 25, 2026

Alkermes (ALKS) Unveils Promising Data on Alixorexton for Narcol - GuruFocus

GuruFocus - Apr 16, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment